If you've ever sat in a doctor's office and heard "well, I don't really see cysts on your ultrasound" used as a reason to brush off your symptoms, this one's for you.
As of today, PCOS is officially PMOS. Polyendocrine Metabolic Ovarian Syndrome. Published in The Lancet this morning, announced at the European Congress of Endocrinology in Prague, backed by 56 patient and professional organizations worldwide including the Endocrine Society. This didn't happen overnight. It took 14 years, over 22,000 survey responses from patients and clinicians across every region of the world, and multiple rounds of international workshops to land here.
The old name was quietly doing real harm. "Polycystic" sent everyone chasing cysts that most people with this condition don't actually have. The WHO estimates that 70% of people with PMOS are undiagnosed. A name that points doctors and patients toward the wrong thing for decades contributes to a number like that.
PMOS corrects the record. "Polyendocrine" means multiple hormone systems are involved, not one isolated ovarian quirk. "Metabolic" finally puts insulin resistance, blood sugar dysregulation, and cardiovascular risk front and center, because that's where the science has been pointing for years. The mechanism is pretty clear at this point: elevated insulin signals the ovaries to produce excess testosterone, and that cascade touches skin, weight, mood, energy, and fertility simultaneously. When the name makes that visible, it changes what gets looked for and what gets treated.
For this community, the name is new. The reality has always been the same.
Our Lore PCOS collection was built on that reality from the start. The formulas address what's actually happening hormonally, not what the old label implied. That doesn't change. If anything, today's news just confirms the direction we've been moving all along.
0 comments